3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Minimal Change Disease: new trials by email Literature Review of Minimal Change Disease trials Research Report on Minimal Change Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease adalimumab - FSGS, MCD | Phase 2 | Completed | University of Michigan | 7 | 2019-10-02 | 2024-10-30 |
| Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) Abatacept, Normal Saline, D5W - Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Phase 2 | Completed | Bristol-Myers Squibb | 36 | 2016-03-09 | 2021-03-05 |
| Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome Tacrolimus - Minimal Change Disease | Phase 2 / Phase 3 | Completed | Seoul National University Hospital | 20 | 2010-06-01 | 2011-08-16 |
Nephrosis, Lipoid (3) · Glomerulosclerosis, Focal Segmental (2) · Nephrotic Syndrome (2) · Kidney Diseases (1) · Macular dystrophy, corneal type 1 (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Nephrosis (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Glomerulonephritis (2) · Kidney Diseases (2) · Nephritis (2)
Abatacept (1) · Adalimumab (1) · Glucose (1) · Saline Solution (1) · Tacrolimus (1) · Water (1)
Bristol-Myers Squibb (1) · Seoul National University Hospital (1) · University of Michigan (1)
United States (2) · South Korea (1)
Zubin Modi, MD (1)
PMID 35224732, PMID 35230699, PMID 38724717, PMID 39808779, PMID 40337980
2015 (1)